Last updated 2026-07-26
- Raised $1.5M Seed round led by Peregrine Ventures, May 2023
- Raised Series A, Jun 2024
- Raised grant, Jun 2024
Total raised
$1.5M
Last: Undisclosed Round 2024-07
Stage
Seed
Founded
2022
Headcount
10
HQ
Or Yehuda, Israel
Sector
Health Tech & Life Sciences
About
Kanso Diagnostics is an Israeli startup that aims to revolutionize molecular diagnostics by providing affordable, lab-grade tests that are accessible anywhere, operable by anyone, and deliver results in minutes. Their novel platform can accurately detect multiple pathogens and genetic biomarkers from a single sample, reducing diagnosis time from days to minutes. The technology offers PCR-grade accuracy with the convenience of rapid home testing, providing an end-to-end solution for diagnosing bacterial and viral infections anytime, anywhere.
Funding history · 3 rounds · $1.5M total
2024-06
A Round
Undisclosed
2024-06
Grant
Undisclosed
2023-05
Seed
$1.5M
★ Peregrine VenturesBecton Dickinson
Headcount over time
From 5 (2024-02) to 7 (2025-10) · +2 (+40%) · 5 points · source: Finder history + radar grounding
Q&A
- What is Kanso Diagnostics' primary focus?
- Kanso Diagnostics develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need, aiming to provide affordable and accessible tests that deliver results in minutes.
- When was Kanso Diagnostics founded?
- Kanso Diagnostics was founded in March 2022.
- How many employees does Kanso Diagnostics currently have?
- Kanso Diagnostics has 10 employees, which falls within the 1-10 employee bucket.
- What is the total amount of funding Kanso Diagnostics has raised to date?
- Kanso Diagnostics has raised a total of $2,000,000 USD.
- Who are the co-founders of Kanso Diagnostics?
- The co-founders of Kanso Diagnostics are Roy Rabinowitz, who serves as CEO, and Omer Stoller, who is the CTO.
- What is the latest funding round Kanso Diagnostics received?
- Kanso Diagnostics received a Grant round in July 2024.
- What is Kanso Diagnostics' current product stage?
- Kanso Diagnostics' product is currently in the alpha stage.
Team · 2
Roy Rabinowitz
Founder · Co-founder, CEO
Omer Stoller
Founder · Co-founder, CTO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesAssistive DevicesDiagnostics Devices
Technologies
BiologicalsMicroorganismsGenesMolecules
Target customers
Healthcare & Life SciencesHealthcarePatientsInsurance CompaniesProvidersMedical Devices IndustryMedical EquipmentLife SciencesBiotechnology
Business model
B2B2CB2B
Highlights
1 PatentsVerified
Tags
molecular-biologydiagnosticsinfectious-diseasebiotechnology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | kansodx.com |
|---|---|
| linkedin.com/company/86834526 |
Identifiers & details
| Legal name | KANSO DIAGNOSTICS LTD |
|---|---|
| Founded | 2022-3 |
| Employees (exact) | 10 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | kansodx.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516574464 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2022-03-06 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 3 — people (1), annual_report (2) |
| Registered address | נתניהו יהונתן 6 אור יהודה |
Recent registry events
| Date | Event |
|---|---|
| 2026-02-23 | עדכון בעלי תפקידים |
| 2026-01-20 | דו~ח שנתי-הוספת בעל תפקיד |
| 2026-01-20 | דו~ח שנתי-שינוי בהוראות בתקנון |